Labcorp Launches Marker by Labcorp™ Genetic Health Panel, Expanding Consumer Access to Hereditary Genetic Risk Testing
PR Newswire
BURLINGTON, N.C., July 27, 2026
New offering analyzes 163 genes linked to more than 100 medically actionable conditionsIncludes genetic counseling support to help consumers understand results and take informed next stepsConsumers can now access biomarker and hereditary genetic testing from a single source through Labcorp OnDemandBURLINGTON, N.C., July 27, 2026 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the launch of Marker by Labcorp™ Genetic Health Panel, a new offering designed to help consumers better understand inherited risks associated with more than 100 medically actionable health conditions. Available through Labcorp OnDemand, the panel analyzes 163 genes associated with hereditary cancer, cardiovascular conditions and metabolic conditions and includes access to licensed genetic counselors to help consumers understand their results and discuss appropriate next steps. The Marker by Labcorp Genetic Health Panel is backed by Labcorp's established expertise in clinical genetic testing through Labcorp Genetics and its Invitae genetic testing capabilities.
